Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Mercury in vaccines from the Australian childhood immunization program schedule.

Austin DW, Shandley KA, Palombo EA.

J Toxicol Environ Health A. 2010;73(10):637-40. doi: 10.1080/15287391003613994.

PMID:
20391108
2.

An assessment of thimerosal use in childhood vaccines.

Ball LK, Ball R, Pratt RD.

Pediatrics. 2001 May;107(5):1147-54. Review.

PMID:
11331700
3.

[Mercury in vaccines].

Hessel L.

Bull Acad Natl Med. 2003;187(8):1501-10. Review. French.

PMID:
15146581
4.

Exposure to mercury during the first six months via human milk and vaccines: modifying risk factors.

Dórea JG.

Am J Perinatol. 2007 Aug;24(7):387-400. Epub 2007 Jun 12. Review.

PMID:
17564957
5.

Thiomersal in vaccines: is removal warranted?

Clements CJ, Ball LK, Ball R, Pratt RD.

Drug Saf. 2001;24(8):567-74. Review.

PMID:
11480489
6.

The evidence for the safety of thiomersal in newborn and infant vaccines.

Clements CJ.

Vaccine. 2004 May 7;22(15-16):1854-61. Review.

PMID:
15121295
7.

When science is not enough - a risk/benefit profile of thiomersal-containing vaccines.

Clements CJ, McIntyre PB.

Expert Opin Drug Saf. 2006 Jan;5(1):17-29. Review.

PMID:
16370953
8.

The role of mercury in the pathogenesis of autism.

Bernard S, Enayati A, Roger H, Binstock T, Redwood L.

Mol Psychiatry. 2002;7 Suppl 2:S42-3. Review. No abstract available.

9.

Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: systematic review of randomized controlled trials and quasi-randomized controlled trials.

Taddio A, Ilersich AL, Ipp M, Kikuta A, Shah V; HELPinKIDS Team.

Clin Ther. 2009;31 Suppl 2:S48-76. doi: 10.1016/j.clinthera.2009.07.024. Review.

PMID:
19781436
10.

Vaccine adverse events: separating myth from reality.

Kimmel SR.

Am Fam Physician. 2002 Dec 1;66(11):2113-20. Review.

11.

[Safety of thimerosal containing vaccines. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society].

Muñoz M A, Abarca V K, Jiménez de la J J, Luchslnger F V, O'Ryan G M, Ripoll M E, Valenzuela B MT, Vergara F R.

Rev Chilena Infectol. 2007 Oct;24(5):372-6. Epub 2007 Oct 26. Review. Spanish.

12.

Mercury exposure in children: a review.

Counter SA, Buchanan LH.

Toxicol Appl Pharmacol. 2004 Jul 15;198(2):209-30. Review.

PMID:
15236954
13.

Making sense of epidemiological studies of young children exposed to thimerosal in vaccines.

Dórea JG.

Clin Chim Acta. 2010 Nov 11;411(21-22):1580-6. doi: 10.1016/j.cca.2010.07.008. Epub 2010 Jul 16. Review.

PMID:
20638374
14.
15.

Vaccines and autism: evidence does not support a causal association.

DeStefano F.

Clin Pharmacol Ther. 2007 Dec;82(6):756-9. Epub 2007 Oct 10. Review.

PMID:
17928818
16.

A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness.

Geier DA, Sykes LK, Geier MR.

J Toxicol Environ Health B Crit Rev. 2007 Dec;10(8):575-96. Review.

PMID:
18049924
17.

Postlicensure epidemiology of childhood vaccination: the Danish experience.

Hviid A.

Expert Rev Vaccines. 2006 Oct;5(5):641-9. Review.

PMID:
17181438
18.

Immunizations, immunology, and autism.

Chez MG, Chin K, Hung PC.

Semin Pediatr Neurol. 2004 Sep;11(3):214-7. Review.

PMID:
15575416
19.

Does antigenic overload exist? The role of multiple immunizations in infants.

Gregson AL, Edelman R.

Immunol Allergy Clin North Am. 2003 Nov;23(4):649-64. Review.

PMID:
14753385
20.

Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders.

Bigham M, Copes R, Srour L.

Can Commun Dis Rep. 2002 May 1;28(9):69-80. Review. English, French. No abstract available.

Supplemental Content

Support Center